RETHYMIC CONNECT
"RETHYMIC CONNECT" is a trademark owned by Sumitomo Pharma Co., Ltd., filed at the WIPO on June 17, 2026. It is on file and covers classes 35, 41, 44 and 45.
- Status
- Mixed
- Filed
- June 17, 2026
- Registered
- Not yet
- Expires
- June 17, 2036
- Application no.
- Not recorded
- Registration no.
- 1944735
- Office
- WIPO
- World Intellectual Property Organization
- Mark type
- Trademark
- 4 classes
Who owns RETHYMIC CONNECT
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Sumitomo Pharma Co., Ltd.
Japan
Representative
SATO Shunji
What the mark covers
The products and services RETHYMIC CONNECT is filed for, grouped by Nice class.
Operation of businesses for others in the field of healthcare; healthcare operations management services, namely, connecting patients to qualified healthcare resources in the nature of administrative services relating to the referral of patients.
Educational services, namely, organizing and conducting classes, seminars, conferences, symposiums and workshops in the health and medical field; educational services, namely, organizing and conducting classes, seminars, conferences, symposiums and workshops in the field of pharmaceutical, biomedical and biological therapeutic research; educational services, namely, organizing and conducting classes, seminars, conferences, symposiums and workshops for patients and their families and caregivers regarding the diagnosis, treatment and care of rare diseases and disorders and immunological diseases and disorders; healthcare education.
Providing health information and medical information; providing information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders and conditions; providing information to patients and their families and caregivers relating to the diagnosis, treatment and care of patients with rare diseases and disorders and immunological diseases and disorders; medication management and disease management being health care; patient advocacy services being advocacy services relating to health issues.
Patient advocacy services being legal advocacy services; non-therapeutic customized support counseling for patients with congenital athymia; providing emotional support for patients and their families via interactive on-line forums; providing companionship services for families of patients with threatening disorders.
About RETHYMIC CONNECT
Who owns the trademark "RETHYMIC CONNECT"?
The WIPO trademark "RETHYMIC CONNECT" is owned by Sumitomo Pharma Co., Ltd.
What is the status of "RETHYMIC CONNECT"?
Its status at the WIPO is: mixed.
Get this data via the API
Everything on this page comes from the Signa API. Pull RETHYMIC CONNECT and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_a9b98cbb-6845-46e7-8e19-fb7c13aae0e7
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_a9b98cbb-6845-46e7-8e19-fb7c13aae0e7",
"object": "trademark",
"mark_text": "RETHYMIC CONNECT",
"status": {
"primary": "mixed",
"stage": "mixed"
},
"office_code": "WO",
"application_number": null,
"filing_date": "2026-06-17",
"nice_classes": [
35,
41,
44,
45
],
"owners": [
{
"name": "Sumitomo Pharma Co., Ltd.",
"entity_id": "ent_019eb7c2-6ca2-723d-862c-09f551bc3fdc"
}
]
}